Breast Cancer News

CancerConnect breast cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of breast cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of breast cancer treatment and survivorship.

Share


Recent Breast Cancer News


Should all Breast Cancer Patients Be Treated With the Bone Health Drug Xgeva®? (February 4, 2016)

The bone health agent Xgeva® (denusomab) appears to delay the time to cancer progression and improve survival among early stage breast cancer patients treated with aromatase inhibitors. Its use should... Continue Reading

Hormone Drug Arimidex® (Anastrozole) Cuts Postmenopausal Breast Cancer Risk By Half (January 29, 2016)

Excerpted from: Advances in Cancer Research And Treatment: 2015 Year In Review The aromatase inhibitor Arimidex has been found to reduce the risk of breast cancer by 53 percent in high-risk postmenopausal... Continue Reading

ASCO Publishes Breast Cancer Survivorship Guidelines (January 25, 2016)

The American Society of Clinical Oncology (ASCO), in collaboration with the American Cancer Society (ACS), have released updated guidelines regarding follow-up care for breast cancer survivors. The updated... Continue Reading

Quality of Life Helps Determine Type of Hormone Treatment in Early Breast Cancer (January 20, 2016)

Quality of life issues and different side effects caused by treatment may help determine which type of hormone therapy is most appropriate for postmenopausal women with ductal carcinoma in situ, particularly... Continue Reading

Atezolizumab Plus Abraxane Promising New Treatment for Triple-Negative Breast Cancer (January 7, 2016)

The investigative agent, atezolizumb, in addition to the chemotherapy agent, Abraxane (nab-paclitaxel), provides high anti-cancer responses among patients with triple-negative breast cancer. These results... Continue Reading

Conjugate Drug Extends Survival in Patients with Advanced HER2-Positive Breast Cancer (January 6, 2016)

Patients with metastatic, HER2-positive breast cancer received a combination antibody/chemotherapy drug in a phase 3 clinical trial survived longer, on average, than patients receiving other treatments.... Continue Reading

FDA Clears Marketing Approval for Device to Reduce Hair Loss during Chemotherapy (January 4, 2016)

The United States Food and Drug Administration (FDA) cleared for marketing the first cooling cap to reduce hair loss due to chemotherapy. The cooling cap (Dignitana DigniCap Cooling System) is to be used... Continue Reading

Adding Carboplatin to Pre-surgery Chemotherapy Improves Survival for Patients with Triple-Negative Breast Cancer (December 22, 2015)

Adding carboplatin to pre-surgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer (TNBC), according to results from a German clinical study released at the San... Continue Reading

Adding Carboplatin to Pre-surgery Chemotherapy Improves Survival for Patients with Triple-Negative Breast Cancer (December 21, 2015)

Adding carboplatin to pre-surgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer (TNBC), according to results from a German clinical study released at the San... Continue Reading

Radiation After Lumpectomy Improves Outcomes Among Elderly with Triple-Negative Breast Cancer (November 30, 2015)

The addition of radiation therapy following a lumpectomy appears to significantly improve outcomes among elderly women with triple-negative breast cancer. These results were recently presented at the 2015... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS